Intracoronary administration of levosimendan in acute coronary syndrome with decreased left ventricular ejection fraction: a case series
Journal of Cardiothoracic and Vascular Anesthesia(2015)
Abstract
In patients (pts) undergoing cardiac surgery, intracoronary (IC) administration of levosimendan can provide optimal regional distribution, enabling favourable effects (cardioprotective and positive inotropic), and avoiding potentially harmful systemic hypotension. This may be beneficial in ischemic heart disease and reduced left ventricular ejection fraction (LVEF).
MoreTranslated text
Key words
levosimendan,left ventricular ejection fraction,intracoronary syndrome
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined